Timothy E Reddy

Associate Professor of Biostatistics & Bioinformatics,

Appointments and Affiliations

  • Associate Professor of Biostatistics & Bioinformatics,
  • Associate Professor in Molecular Genetics and Microbiology

Contact Information

  • Office Location: 101 Science Drive, 2347 Ciemas, Duke Box 3382, Durham, NC 27708
  • Office Phone: (919) 564-9536
  • Email Address: tim.reddy@duke.edu
  • Websites:

Education

  • Ph.D. Boston University, 2007

Courses Taught

  • CBB 510S: Computational Biology Seminar
  • CBB 511: Journal Club
  • CBB 591: Independent Study
  • CBB 700: Internship

In the News

Representative Publications

  • Zhu, Xinyu, Joseph D. Trimarco, Courtney A. Williams, Alejandro Barrera, Timothy E. Reddy, and Nicholas S. Heaton. “ZBTB7A promotes virus-host homeostasis during human coronavirus 229E infection.” Cell Rep 41, no. 4 (October 25, 2022): 111540. https://doi.org/10.1016/j.celrep.2022.111540.
  • Luo, Kaixuan, Jianling Zhong, Alexias Safi, Linda K. Hong, Alok K. Tewari, Lingyun Song, Timothy E. Reddy, Li Ma, Gregory E. Crawford, and Alexander J. Hartemink. “Profiling the quantitative occupancy of myriad transcription factors across conditions by modeling chromatin accessibility data.” Genome Res 32, no. 6 (June 2022): 1183–98. https://doi.org/10.1101/gr.272203.120.
  • Kadur Lakshminarasimha Murthy, Preetish, Rui Xi, Diana Arguijo, Jeffrey I. Everitt, Dewran D. Kocak, Yoshihiko Kobayashi, Aline Bozec, et al. “Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity.” Dev Cell 57, no. 3 (February 7, 2022): 310-328.e9. https://doi.org/10.1016/j.devcel.2022.01.006.
  • Reddy, T. E. “The functional genome: epigenetics and epigenomics.” In Genomic and Precision Medicine: Oncology, Third Edition, 29–54, 2022. https://doi.org/10.1016/B978-0-12-800684-9.00017-4.
  • Kabadi, Ami M., Leah Machlin, Nikita Dalal, Rhianna E. Lee, Ian McDowell, Nirav N. Shah, Lauren Drowley, Scott H. Randell, and Timothy E. Reddy. “Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.” J Cyst Fibros 21, no. 1 (January 2022): 164–71. https://doi.org/10.1016/j.jcf.2021.04.008.